London-based Ethos Partners, one of Europe’s most active lower mid-market investors, has acquired the entire issued share capital of Faringdon-based Bray Group.
The transaction will support the business in its ambitious plans to expand its product lines and client base in the UK and internationally.
Oxfordshire based Bray Group operates through three established industry brands - Avoca, Portia, and Bray Healthcare – focused on skin and wound treatments and women’s health.
The Group’s customers include national health services, hospitals, clinics, wholesalers, distributors, retail pharmacies and medical practitioners across 35 international markets, including the UK, Canada, Australia, France, Poland and the Middle East.
Sally Naunton, CEO of Bray Group said: “We are delighted to be backed by Ethos and believe that our collective ambition and enthusiasm for Bray will result in an exciting future for our company. Our commitment to shining the spotlight on uncomplicated healthcare and connecting patients and clinicians with intuitive products remains unwavering. We felt fully supported by our advisers, Gateley Legal. Their impressive depth of expertise, commercial approach and responsiveness was critical in ensuring a successful outcome for all stakeholders. We are delighted with the result and grateful for the support Adam, Victoria and their entire team provided us.”
